Biomarker-Based Signature of Alzheimer’s Disease in Pre-MCI Individuals

Biomarker-Based Signature of Alzheimer’s Disease in Pre-MCI Individuals

Alzheimer’s disease (AD) pathology begins decades before the onset of clinical symptoms. It is recognized as a clinicobiological entity, being detectable in vivo independently of the clinical stage by means of pathophysiological biomarkers. Accordingly, neuropathological studies that were...

Full description

Bibliographic Details
Main Authors: Elena Chipi, Nicola Salvadori, Lucia Farotti, Lucilla Parnetti
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Series:Brain Sciences
Subjects:
preclinical AD
pre-MCI
biomarkers
neuropsychological assessment
neuropathological findings
Online Access:https://www.mdpi.com/2076-3425/9/9/213

Internet

https://www.mdpi.com/2076-3425/9/9/213

Similar Items